Showing results (111-120 of 118) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Toxicology Reports|October 21, 2020
Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for <i>N</i>-Acetyltransferase 2Kyung U Hong, Mark A Doll, Angeliki Lykoudi, et al.Antioxidants (Basel, Switzerland)|July 2, 2021
Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin PharmacokineticsAdrienne M Bushau-Sprinkle, Michelle T Barati, Yuxuan Zheng, et al.Journal of Lipid Research|February 13, 2022
Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injurySophia M Sears, Tess V Dupre, Parag P Shah, et al.International Journal of Cancer|June 17, 2011
Hair dye use and risk of bladder cancer in the New England bladder cancer studyStella Koutros, Debra T Silverman, Dalsu Baris, et al.Molecular Pharmacology|January 2, 2024
Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and DiseaseWhitney J Richardson, Sophia B Humphrey, Sophia M Sears, et al.Pharmacogenetics and Genomics|August 27, 2010
A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European backgroundMontserrat García-Closas, David W Hein, Debra Silverman, et al.American Journal of Physiology. Renal Physiology|December 15, 2015
Suramin protects from cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.Journal of Lipid Research|May 12, 2017
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injuryTess V Dupre, Mark A Doll, Parag P Shah, et al.Pageof 12